Sansome, D.J.Jones, K.L.Horowitz, M.Rayner, C.K.Wu, T.2025-07-142025-07-142020British Journal of Clinical Pharmacology, 2020; 86(12):2538-25390306-52511365-2125https://hdl.handle.net/2440/145913Letter to the EditorAbstract unavailableen© 2020 The British Pharmacological SocietyLetter to editor; statins; insulin resistance; type 2 diabetes (T2D); increase riskHumansDiabetes Mellitus, Type 2Bile Acids and SaltsBlood GlucoseHydroxymethylglutaryl-CoA Reductase InhibitorsGlycemic ControlStatins and glycaemic control in type 2 diabetes: Are bile acids relevant?Journal article10.1111/bcp.142742024-05-06527875Sansome, D.J. [0000-0002-5618-9602]Jones, K.L. [0000-0002-1155-5816]Horowitz, M. [0000-0002-0942-0306]Rayner, C.K. [0000-0002-5527-256X]Wu, T. [0000-0003-1656-9210]